Phase I study of the combination of nedaplatin, adriamycin and 5-fluorouracil for treatment of advanced esophageal cancer

Diseases of the Esophagus

Volumn 17, Issue 3, 2004, Pages 247-250

  Hirao, Motohiro ^a   Fujitani, K ^a   Tsujinaka, T ^a  

^a OSAKA NATIONAL HOSPITAL   (Japan)

Author keywords

Cancer; Chemotherapy; Esophagus; Nedaplatin; Phase I

Indexed keywords

AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; CREATININE; DOXORUBICIN; FLUOROURACIL; NEDAPLATIN; PLATINUM COMPLEX;

ADVANCED CANCER; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG RESPONSE; DRUG TOLERABILITY; ESOPHAGUS CANCER; HEART DISEASE; HUMAN; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MAXIMUM TOLERATED DOSE; NAUSEA; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; DIARRHEA; DOXORUBICIN; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NAUSEA; NEUTROPENIA; ORGANOPLATINUM COMPOUNDS; PLATELET COUNT; TREATMENT OUTCOME;

EID: 5744229803     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2004.00416.x     Document Type: Article

References (16)

1. Leichman L, Berry B T. Experience with cisplatin in treatment regimens for esophageal cancer. Semin Oncol 1991; 18: 64-72.
2. Ajani A J. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Semin Oncol 1994; 21: 474-82.
3. Totani T, Aono K, Komura M. Synthesis of (Glycolato-o,o′) diammine platinum (II) and its related complexes. Chemistry Letters 1986; 4: 429-32.
4. Taguchi T, Wakui A, Nabeya K et al. A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. Jpn J Cancer Chemother 1992; 19: 483-8.
5. Furukawa S, Yoshida T, Tukuda M et al. Experimental study on combination chemotherapy with platinum compounds and 5-fluorouracil. Jpn J Cancer Chemother 1989; 16: 419-22.
6. Fuwa N, Kodaira T, Kamata M et al. Phase I study of combination chemotherapy with 5-FU and nedaplatin. Am J Clin Oncol (CCT) 2002; 25: 565-9.
7. Gisselbrecht C, Calvo F, Mignot L et al. Fluorouracil, adriamycin, and cisplatin (FAP): combination chemotherapy of advanced esophageal carcinoma. Cancer 1983; 52: 974-7.
8. Wagener D J T, Yap S H, Wobbes T et al. Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer. Cancer Chemother Pharmacol 1985; 15: 86-7.
9. Japanese society for esophageal diseases. Guide Lines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus, 9th edn. Tokyo: the Society, 1999.
10. Coonley C J, Bains M, Hilaris B, Chapman R, Kelsen D P. Cisplatin and bleomycin in the treatment of esophageal carcinoma, a final report. Cancer 1984; 54: 2351-5.
11. Engstrom P F, Lavin P T, Klaassen D J. Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma. Cancer Treat Rep 1983; 67: 713-15.
12. Dinwoodie W R, Bartolucci A A, Lyman G H, Velez-Garcia E, Martelo O J, Sarma P R. Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a southeastern cancer Study Group trial. Cancer Treat Rep 1986; 70: 267-70.
13. Kies M S, Rosen S T, Tsang T K et al. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer 1987; 60: 2156-60.
14. Iizuka T, Kakegawa T, Ide H et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese esophageal oncology group trial. Jpn J Clin Oncol 1992; 22: 172-6.
15. Yoshioka T, Gamoh M, Shineha R et al. A new combination chemotherapy with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for advanced esophageal cancers. Intern Med 1999; 38: 844-8.
16. Muro K, Ando T, Nishimaki A et al. A phase II study of nadaplatin and 5-fluorouracil in metastatic squamous cell carcinoma of the esophagus: The Japanese clinical oncology group (JCOG) trial (JCOG 9905). Proc ASCO 2003; 22: 1112.